FEATURED EDITORIAL
This scientific article presents a summary of the formulation development strategy of a JAK1 inhibitor extended-release tablet, with a focus on experimental design, data interpretation, and formulation decision-making.
- Radiopharmaceuticals: Navigating FDA Guidance And CMC Considerations
- Designing Our Way Toward Circular RNA Medicines With AI
- Will Genome Modifications Define Next-Gen AAV Vectors?
- Formulation Is Key For Y-mAbs' Self-Assembling Antibody
- ADCs Unleashed: Navigating Development Hurdles In Targeted Cancer Therapy
- Protecting Intellectual Property In The Genomics Revolution
- PheWAS Is Your Friend
FEATURED APPLICATION CONTENT
-
Decarbonizing healthcare and pharmaceuticals is vital to meet climate goals and safeguard public health. Learn why these energy-intensive sectors must act swiftly to reduce emissions and navigate complex global supply chains.
-
Optimize your protein purification workflow with tangential flow filtration by comparing membrane performance and exploring how protein concentration impacts flux and MWCO selection in lab-scale systems.
-
Raman spectroscopy has revolutionized manufacturing through real-time monitoring. Explore a system that enables a seamless calibration model transfer from small- to large-scale bioreactors to enhance scalability and efficiency.
-
Sterility in injectable drug manufacturing is vital for patient safety and efficiency. Discover how biofluorescent particle counters revolutionize contamination control, regulatory compliance, and operational excellence in modern pharma.
-
Are robotic gloveless isolators the key to smarter, safer, scalable solutions? Discover how they can revolutionize aseptic filling by reducing contamination, minimizing waste, and enhancing manufacturing flexibility.
-
CDMOs must innovate production architectures to meet the demands of advanced therapeutics to ensure a reliable supply and compliance. Discover how these approaches advance modern medicine and improve patient outcomes.
-
Delve into the intricate workflow employed for the discovery and characterization of monoclonal antibodies (mAbs) targeting the Delta spike protein.
-
Overcoming the limitations of current proximity inducers requires optimizing cooperativity. Learn how enhancing target affinity can lead to smaller, more effective therapeutics with better safety profiles.
-
Maximize your research potential by overcoming workflow bottlenecks. This piece explores flexible strategies for increasing throughput and integrating automation seamlessly into your laboratory operations.
-
Continuous processes enhance product quality, yield, and cost savings. Explore transitioning a fed-batch process to perfusion using a small batch bioreactor system to optimize cell culture conditions and comparing performances.
-
Discover how a company overcame cell generation challenges by using a system that achieves a seed ratio of 1:120 and saves four days in seed preparation time.
-
Efforts to enhance biopharmaceutical manufacturing focus on boosting production capacity sustainably and economically. Explore how optimizing processes with single-use solutions and monitoring leachables ensures product quality.
FEATURED NEWS HEADLINES
- Pattern To Test Novel AI-Discovered Molecular De Novo Drug For Treatment Of Multiple Hard-To-Treat Cancers
- Lisata Therapeutics And GATC Health Expand Relationship To Advance AI-Driven Drug Discovery And Development
- ArkBio's New Drug Application For ADHD Therapeutic Azstarys Accepted And Granted Priority Review By China NMPA
- Singota Solutions Opens New European Facility
- Circle Pharma Receives FDA Orphan Drug Designation For CID-078 For The Treatment Of Small Cell Lung Cancer
- Fauna Bio Launches Fauna Brain AI Platform To Accelerate Drug Discovery Inspired By Nature's Most Resilient Species
- NextCure And Simcere Zaiming Announce Strategic Partnership For A Novel Antibody-Drug Conjugate Targeting CDH6
- Aquestive Therapeutics Announces FDA Acceptance Of New Drug Application And PDUFA Date For Anaphylm™ For The Treatment Of Severe Allergic Reactions
- BioAro Launches PanOmiQ™ Research In Breakthrough For AI-Driven Drug Discovery And Multi-Omics
- Startup's Biosensor Makes Drug Development And Manufacturing Cheaper
ARCHIVED NEWSLETTER
- 06.19.25 -- Your helping hand in filtration for high concentration drugs.
- 06.17.25 -- PheWAS Is Your Friend
- 06.11.25 -- From Complexity To Efficiency: The Future Of Drug Development
- 06.10.25 -- Your Go-To Guide For CNS Drug Development
- 06.10.25 -- Understanding The Impact Of An RMP On Patient Risks Using Relational Risk Analysis